Ceci est une version HTML d'une pièce jointe de la demande d'accès à l'information 'Stakeholder contacts on TTIP (since 12 December 2014)'.



Ref. Ares(2015)1644728 - 17/04/2015
Ref. Ares(2016)6183596 - 28/10/2016
From: 
 (TRADE) 
Sent: 
17 April 2015 13:39 
To: 
 (TRADE) 
Cc: 
 (TRADE) 
Subject: 
FW:  
 
 
Dear
, please put this in Ares and circulate for information only to 

; Rupert Schlegelmich, 


 
;  This is a meeting with the industry, so
 might wish to put it in her list 
with the contacts with the industry. 
 
 
A meeting took place on 16 April 2015, between the Standing Committee of European 
doctors (CPME, 

 and British Medical Association, ) and the B1 (
 

) and F3 (
) units to discuss their concerns on health 
issues in the context of TTIP. SCED made clear that they wish to close any possible tiny 
loophole in the agreement and in particular they expressed concerns  on the application 
of ISDS on health services. They proposed a full carve-out of on health services from the 
agreement to avoid such applications, as they said that following discussions with the F2 
they understood that they cannot exclude the application of ISDS on health services. 
Their concern stems from possible re-nationalisation efforts of the UK government in the 
future and from the question whether following possible future extensive privatization 
of the healthcare sector in UK it can still qualify as a public utility or a publicly funded 
service (their assumption is that in the event of further privatisation of the NHS  it 
cannot be any longer considered as a public utility and therefore cannot be subject to 
the public utility/publicly funded health services protection of the agreement). Given 
that they only represent health professionals and not the entire health industry (i.e. 
hospitals, providers of ambulance services) it was not possible for them to measure the 
impact of an exemption from the application of the ISDS of the health services for 
hospitals etc as in this case they would miss the benefits ensured through ISDS.COM 
explained what we negotiate in market access in health services in TTIP and re-assured 
SCED that there are no loopholes in the agreement. COM also opposed to any exclusion 
of health services from the scope of TTIP and reminded them of the EU GATS 
commitments. It was clear from the discussion that there are no genuine market access 
concerns in health services but rather issues related to the application of ISDS. CPME 
noted also some interest on regulatory issues, notably the fear of potential impact of 
TTIP on the European Medicines Agency (EMA) policy on disclosure of clinical trials (CT) 
data and on TTIP impact on the EU system for the approval of medical devices. COM 
briefly explained which issues are being discussed on the pharmaceuticals and medical 
devices sectorial discussions (as set in publically available position papers) and confirmed 
that EMA policy on disclosure of CT data will not be questioned by TTIP. TTIP will also not 
impact the revision of the EU legislation for medical devices currently on going nor the 
way medical devices are authorized to be placed in the EU market.   

 
Thank you,